Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I3WC
|
||||
Former ID |
DIB000358
|
||||
Drug Name |
RO-4929097
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Roche
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H20F5N3O3
|
||||
InChI |
InChI=1S/C22H20F5N3O3/c1-20(2,18(32)28-11-21(23,24)22(25,26)27)19(33)30-16-14-9-4-3-7-12(14)13-8-5-6-10-15(13)29-17(16)31/h3-10,16H,11H2,1-2H3,(H,28,32)(H,29,31)(H,30,33)/t16-/m0/s1
|
||||
InChIKey |
OJPLJFIFUQPSJR-INIZCTEOSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
104253224, 121143589, 124757349, 125164153, 135323407, 135727396, 136348257, 136349997, 136367552, 136367801, 137276006, 137710929, 152258320, 160647159, 162011370, 162037674, 162202738, 163907988, 174006710, 174530815, 178103910, 184819500, 198939144, 223705127, 223929894, 227593850, 243630441, 252110184, 252162573, 252216215
|
||||
Target and Pathway | |||||
Target(s) | Gamma-secretase | Target Info | Modulator | [531882] | |
KEGG Pathway | Notch signaling pathway | ||||
Alzheimer's disease | |||||
Reactome | Nuclear signaling by ERBB4 | ||||
Regulated proteolysis of p75NTR | |||||
NRIF signals cell death from the nucleus | |||||
Activated NOTCH1 Transmits Signal to the Nucleus | |||||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
NOTCH2 Activation and Transmission of Signal to the Nucleus | |||||
EPH-ephrin mediated repulsion of cells | |||||
References | |||||
Ref 531882 | Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors. J Clin Oncol. 2012 Jul 1;30(19):2348-53. | ||||
Ref 542361 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7338). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.